It's the first and only oral GLP-1 drug
Some patients report changes in appetite or food cravings during the transition period, though these effects are generally temporary and related to the physiological adjustments rather than withdrawal symptoms
Moreover, GLP-1RA and DPP-4 inhibitors are approved for the treatment of T2DM and exhibit potential pleiotropic effects on the heart and kidneys, which may be independent of or dependent on the hypoglycemic effects
They stimulate insulin secretion, inhibit glucagon release, and slow gastric emptying, which aids in lowering blood sugar levels and promotes satiety
Poor sleep patterns and disrupted circadian rhythms can reduce GLP-1 secretion by up to 24%
Great options include lean meats, fish, eggs, Greek yogurt, cottage cheese, or legumes